Technical Analysis for NAVB - Navidea Biopharmaceuticals, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.04 | 1.90% | 0.00 |
Earnings due: May 9
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Boomer Buy Setup | Bullish Swing Setup | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Fell Below 20 DMA | Bearish | 1.90% | |
Fell Below 50 DMA | Bearish | 1.90% | |
MACD Bearish Signal Line Cross | Bearish | 1.90% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 1.90% | |
Inside Day | Range Contraction | 1.90% | |
Wide Bands | Range Expansion | 1.90% |
Alert | Time |
---|---|
Possible NR7 | about 17 hours ago |
60 Minute Opening Range Breakout | about 20 hours ago |
Up 1% | about 20 hours ago |
Possible Inside Day | 1 day ago |
20 DMA Support | 2 days ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/09/2024
Navidea Biopharmaceuticals, Inc. Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. The company's radiopharmaceutical development programs include Lymphoseek Injection, a receptor-targeted small-molecule investigational radiopharmaceutical that is used in lymphatic mapping procedures, which are performed to help stage breast cancer and melanoma; and NAV4694, an F-18 radiolabeled positron emission tomography imaging agent, which is used as an aid in the diagnosis of patients with signs or symptoms of cognitive impairment, such as Alzheimer's disease. Its radiopharmaceutical development programs also comprise NAV5001, an Iodine-123 radiolabeled single photon emission computed tomography imaging agent that is used as an aid in the diagnosis of Parkinson's disease and other movement disorders with potential use as a diagnostic aid in dementia; and RIGScan, a radiolabeled monoclonal antibody that is developed as a diagnostic aid for use during surgery to help surgeons locate occult or metastatic cancer, primarily colorectal cancer. It has research and development agreements with University of California, AstraZeneca AB, Alseres Pharmaceuticals, Inc., and The Ohio State University. The company was formerly known as Neoprobe Corporation and changed its name to Navidea Biopharmaceuticals, Inc. in January 2012. Navidea Biopharmaceuticals, Inc. was founded in 1983 and is headquartered in Dublin, Ohio.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Surgery Monoclonal Antibody Alzheimer's Disease Breast Cancer Parkinson's Disease Melanoma Colorectal Cancer Dementia Medical Physics Movement Disorders Tomography Imaging Agent Nuclear Medicine Radiopharmaceuticals Cognitive Impairment Metastasis Iodine Positron Emission Tomography Medicinal Radiochemistry Metastatic Cancer
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 0.276 |
52 Week Low | 0.021 |
Average Volume | 80,886 |
200-Day Moving Average | 0.06 |
50-Day Moving Average | 0.04 |
20-Day Moving Average | 0.04 |
10-Day Moving Average | 0.04 |
Average True Range | 0.01 |
RSI (14) | 48.45 |
ADX | 43.83 |
+DI | 25.39 |
-DI | 6.14 |
Chandelier Exit (Long, 3 ATRs) | 0.03 |
Chandelier Exit (Short, 3 ATRs) | 0.06 |
Upper Bollinger Bands | 0.05 |
Lower Bollinger Band | 0.03 |
Percent B (%b) | 0.42 |
BandWidth | 44.22 |
MACD Line | 0.00 |
MACD Signal Line | 0.00 |
MACD Histogram | 0.0 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.04 | ||||
Resistance 3 (R3) | 0.04 | 0.04 | 0.04 | ||
Resistance 2 (R2) | 0.04 | 0.04 | 0.04 | 0.04 | |
Resistance 1 (R1) | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
Pivot Point | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
Support 1 (S1) | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
Support 2 (S2) | 0.04 | 0.04 | 0.04 | 0.04 | |
Support 3 (S3) | 0.04 | 0.04 | 0.04 | ||
Support 4 (S4) | 0.04 |